Skip to main content
Top
Metadata
Title
Cardioprotective effect of κ1-opioid receptor activation and role of cAMP in its realization
Authors
T. V. Lasukova
L. N. Maslov
A. A. Platonov
N. V. Guzarova
Yu. B. Lishmanov
Publication date
01-01-2007
Publisher
Kluwer Academic Publishers-Consultants Bureau
Published in
Bulletin of Experimental Biology and Medicine / Issue 1/2007
Print ISSN: 0007-4888
Electronic ISSN: 1573-8221
DOI
https://doi.org/10.1007/s10517-007-0007-0

Other articles of this Issue 1/2007

Bulletin of Experimental Biology and Medicine 1/2007 Go to the issue

Translated from Kletochnye Tekhnologii v Biologii i Meditsine (Cell Technologies in Biology and Medicine)

Selective antitumor activity of lymphokine-activated killer cells in vitro

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine